Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO was delisted on the 27th of March, 2020.
7 hedge funds and large institutions have $3.23M invested in Proshares UltraPro NASDAQ Biotechnology in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 2 reducing their positions, and 0 closing their positions.
1,001% more capital invested
Capital invested by funds: $293K → $3.23M (+$2.93M)
75% more funds holding
Funds holding: 4 → 7 (+3)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.5M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$903K |
| 3 |
CG
Cutler Group
San Francisco,
California
|
+$40.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$235K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$186 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $1.85M | +$1.5M | +56,492 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1.11M | +$903K | +33,955 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $166K | -$235K | -8,839 | -64% |
|
|
CG
4
Cutler Group
San Francisco,
California
| $49K | +$40.4K | +1,521 | New |
|
5
Morgan Stanley
New York
| $26K | – | – | – |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $24K | – | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $2K | -$186 | -7 | -11% |
|
UBIO Hedge Fund Activity: Q4 2019 in Review
7 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Proshares UltraPro NASDAQ Biotechnology (UBIO) for Q4 2019, worth a combined $3.23M — up 1,001% from $293K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new UBIO positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $1.5M. The largest seller was Tower Research Capital (TRC), cutting an estimated $235K.
- 7 institutional investors held Proshares UltraPro NASDAQ Biotechnology (UBIO) as of Q4 2019, up from 4 in Q3 2019.
- Funds reported $3.23M of Proshares UltraPro NASDAQ Biotechnology stock for Q4 2019, up 1,001% quarter-over-quarter.
- 3 funds opened new Proshares UltraPro NASDAQ Biotechnology positions in Q4 2019 and 0 closed out, a net change of +3 holders.
- The largest Proshares UltraPro NASDAQ Biotechnology buyer in Q4 2019 was Jane Street, an estimated $1.5M added.
- The largest Proshares UltraPro NASDAQ Biotechnology seller in Q4 2019 was Tower Research Capital (TRC), an estimated $235K sold.
Based on aggregated 13F filings for Q4 2019.